Blog Archives

Motion Sensor Dyskinesia Assessment During Activities of Daily Living

C. Pulliam, M. Burack, J. Giuffrida, T. Mera 66th Annual Meeting Of The American Academy Of Neurology, Philadelphia, PA, 2014


Wearable sensors for quantifying deep brain stimulation washout effects on gait in Parkinson’s disease

E. Brokaw, T. Mera, D. Riley, B. Walter, A. Espay, F. J. Revilla, J. Giuffrida, D. Heldman 66th  Annual Meeting of the American Academy of Neurology, Philadelphia, PA, 2014


PRESS RELEASE: $1.5M NIH Funding To Expand Parkinson’s Telemedicine To Mobile Apps

VIEW PRESS RELEASE 15 APR 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they will be using a $1.5M award from NIH to expand their Parkinson’s monitoring technology to mobile applications. Repositioning GLNT’s Kinesia™ product line with mobile apps strategically aligns with growing trends in domestic and

Read more ›


PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity

VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for Parkinson’s disease diagnostics and treatment.


Clinician Versus Machine: Reliability and Responsiveness of Motor Endpoints in Parkinson’s Disease

D. Heldman, A. Espay, P. Lewitt, and J. Giuffrida Parkinsonism Relat Disord. 2014;20(6):590–5.


PRESS RELEASE: Great Lakes NeuroTechnologies Launches Study to Automatically Classify Abnormal Muscle Tone in Movement Disorders

VIEW PRESS RELEASE [PDF] 15 JAN 2014: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that it is launching a study to determine the feasibility of a clinician-worn glove to objectively evaluate abnormal muscle tone, such as stiff joints or muscle tightness, due to neurological disorders.


Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease

T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.


Tradeshow Event: Partnership in Clinical Trials

The Mirage Hotel Las Vegas, NV March 31 – April 2 2014 Conference home page We will be exhibiting at booth #1305 . We will be demonstrating out Kinesia HomeView and ProView systems. From the 2013 event: This year’s event brings together upwards of 1300 clinical decision makers for four

Read more ›


PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease

VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by adding real-time video conferencing. The research and development are being

Read more ›


PRESS RELEASE: GLNT Awarded Patent For Technology To Treat Parkinson’s Disease With Brain Stimulation During Sleep

VIEW PRESS RELEASE [PDF] 22 JUL 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of stimulating the brain during sleep to treat movement disorder symptoms. The claims cover a

Read more ›